Richard E. Sampliner
#125,250
Most Influential Person Now
Richard E. Sampliner's AcademicInfluence.com Rankings
Richard E. Samplinerphilosophy Degrees
Philosophy
#5848
World Rank
#8767
Historical Rank
Logic
#3055
World Rank
#4157
Historical Rank
Download Badge
Philosophy
Why Is Richard E. Sampliner Influential?
(Suggest an Edit or Addition)Richard E. Sampliner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus (1998) (1706)
- The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. (1992) (1282)
- Radiofrequency ablation in Barrett's esophagus with dysplasia. (2009) (1013)
- Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. (2001) (888)
- Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus (1998) (807)
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B (1990) (757)
- Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. (2000) (752)
- The Natural History of Community-Acquired Hepatitis C in the United States (1993) (623)
- A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. (2004) (556)
- Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus (2002) (470)
- Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. (2011) (446)
- Five-year colon surveillance after screening colonoscopy. (2007) (423)
- Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. (2006) (399)
- Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. (2012) (383)
- Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography. (1970) (365)
- Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus (2004) (351)
- Prospective study of the frequency and size distribution of polyps missed by colonoscopy. (1990) (348)
- The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. (1997) (343)
- Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett’s oesophagus (2003) (311)
- Short segment Barrett's esophagus—the need for standardization of the definition and of endoscopic criteria (1998) (303)
- Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. (1991) (292)
- Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A CostUtility Analysis (2003) (265)
- Adenoma characteristics as risk factors for recurrence of advanced adenomas. (2001) (253)
- Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies (2007) (245)
- Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. (2011) (245)
- Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s oesophagus (2006) (234)
- Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. (1997) (232)
- Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. (2011) (227)
- Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. (1982) (220)
- A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. (2009) (213)
- Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. (1996) (204)
- Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. (1997) (200)
- Intestinal metaplasia of the gastric cardia. (1997) (196)
- Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia (2000) (195)
- Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. (1994) (176)
- A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. (1990) (170)
- Effect of Ambulatory 24-Hour Esophageal pH Monitoring on Reflux-Provoking Activities (1999) (165)
- BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia (2015) (158)
- Medication usage and the risk of neoplasia in patients with Barrett's esophagus. (2009) (157)
- Diagnostic inconsistencies in Barrett's esophagus (1994) (151)
- Erosive Esophagitis and Barrett's Esophagus in Taiwan (A Higher Frequency than Expected) (1997) (140)
- The effects of 13‐cis‐retinoic acid and beta‐carotene on cellular immunity in humans (1991) (136)
- A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. (1999) (136)
- Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. (2001) (127)
- The Liver Histology and Frequency of Clearance of the Hepatitis B Surface Antigen (HBsAg) in Chronic Carriers (1979) (125)
- Risk Factors for Dysplasia in Patients with Barrett's Esophagus (BE): Results from a Multicenter Consortium (2003) (119)
- Squamous Islands in Barrett's Esophagus: What Lies Underneath? (1998) (117)
- The association of body mass index with Barrett's oesophagus (2005) (116)
- Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. (2013) (115)
- Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer risk. (1996) (114)
- A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results (2006) (113)
- The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines. (1996) (112)
- Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. (1989) (105)
- Management of Barrett's Esophagus in the UK: Overtreated and Underbiopsied but Improved by the Introduction of a National Randomized Trial (2008) (99)
- High protein ascites in patients with uncomplicated hepatic cirrhosis (1974) (97)
- Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. (1993) (96)
- Increased Expression and Secretion of Interleukin-6 in Patients with Barrett’s Esophagus (2004) (94)
- Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia. (2017) (93)
- The difference in colon polyp size before and after removal. (1996) (93)
- Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? (2000) (91)
- Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. (1982) (89)
- Are endoscopic measurements of colonic polyps reliable? (1993) (85)
- The Diagnostic Accuracy of Esophageal Capsule Endoscopy in Patients With Gastroesophageal Reflux Disease and Barrett's Esophagus: A Blinded, Prospective Study (2008) (84)
- Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas. (1999) (83)
- Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort. (2013) (83)
- Chromosomal rearrangements in Barrett's esophagus. A premalignant lesion of esophageal adenocarcinoma. (1989) (82)
- Activation of the Interleukin-6/STAT3 Antiapoptotic Pathway in Esophageal Cells by Bile Acids and Low pH: Relevance to Barrett's Esophagus (2007) (81)
- Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group. (1993) (80)
- NSAID effect on sporadic colon polyps. (1993) (79)
- Medical decision analysis of endoscopic surveillance of Barrett’s oesophagus to prevent oesophageal adenocarcinoma (2002) (78)
- Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study. (2006) (76)
- Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus. (1999) (75)
- Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa. (1993) (74)
- Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up. (1999) (74)
- Intestinal metaplasia of the stomach: identification by a selective mucosal staining technique. (1992) (72)
- Endoscopic Surveillance of Columnar-Lined Esophagus: Frequency of Intestinal Metaplasia Detection and Impact of Antireflux Surgery (2003) (72)
- Diphenylhydantoin control of alcohol withdrawal seizures. Results of a controlled study. (1974) (71)
- Long-term follow-up of intestinal metaplasia of the gastric cardia (2000) (70)
- Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. (2001) (70)
- Gastrointestinal cytomegalovirus infection in heart and heart-lung transplant recipients. (1989) (65)
- Ornithine decarboxylase activity in Barrett's esophagus: a potential marker for dysplasia. (1988) (64)
- Histopathology of community acquired chronic hepatitis C. The Sentinel Counties Chronic Non-A, Non-B Hepatitis Study Team. (1992) (64)
- Gastric intestinal metaplasia in ethnic groups in the southwestern United States. (1992) (63)
- Hepatitis C: and miles to go before we sleep. (1989) (63)
- Significance of isolated hepatitis B core antibody in blood donors. (1993) (61)
- Lack of impact of therapy on extent of Barrett's esophagus in 67 patients (2005) (60)
- Ornithine decarboxylase and polyamine levels in columnar upper gastrointestinal mucosae in patients with Barrett's esophagus. (1988) (58)
- Lack of spontaneous regression of tubular adenomas in two years of follow-up. (1997) (58)
- 213 A Randomized, Multicenter, Sham-Controlled Trial of Radiofrequency Ablation (RFA) for Subjects with Barrett's Esophagus (Be) Containing Dysplasia: Interim Results of the Aim Dysplasia Trial (2008) (55)
- Significance of isolated antibody to hepatitis B core antigen determined by immune response to hepatitis B vaccination. (1987) (54)
- Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy. (2017) (53)
- Ablative therapies for the columnar-lined esophagus. (1997) (53)
- Apoptosis Resistance in Barrett's Esophagus: Ex vivo Bioassay of Live Stressed Tissues (2005) (52)
- Calcium, vitamin D, and risk of adenoma recurrence (United States) (2002) (52)
- Design and baseline characteristics of study participants in the Wheat Bran Fiber trial. (1998) (52)
- Barrett's esophagus: update on screening, surveillance, and treatment. (1999) (51)
- Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group. (1994) (50)
- Methylene blue staining for intestinal metaplasia of the gastric cardia with follow-up for dysplasia. (1998) (49)
- Effectiveness of India ink as a long-term colonic mucosal marker. (1992) (48)
- Partial regression of Barrett's esophagus--an inadequate endpoint. (1993) (48)
- Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia? (1997) (46)
- The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment (1996) (46)
- Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett’s Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett’s Esophagus) Consortium (2017) (46)
- Regression of Barrett's esophagus by laser ablation in an anacid environment (1993) (46)
- Two-year incidence of colon adenomas developing after tandem colonoscopy. (1994) (46)
- Acid suppression therapy may not alter malignant progression in Barrett's metaplasia showing p53 protein accumulation (2002) (45)
- The impact of practice guidelines in the management of Barrett esophagus: a national prospective cohort study of physicians. (2001) (45)
- Lower Annual Rate of Progression of Short‐Segment vs Long‐Segment Barrett's Esophagus to Esophageal Adenocarcinoma (2019) (44)
- Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study. (2012) (44)
- Consensus statement on therapeutic endoscopy and bleeding ulcers. Consensus Development Panel. (1990) (42)
- Spontaneous reactivation of hepatitis B in Chinese patients with Hbsag‐positive chronic active hepatitis (1987) (41)
- Progression or regression of barrett's esophagus—is it all in the eye of the beholder? (2003) (41)
- Biomarker studies in reversed Barrett's esophagus (1999) (41)
- Prevalence of Barrett's Esophagus in Hispanics Is Similar to Caucasians (1998) (40)
- Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with alpha-difluoromethylornithine. (1994) (39)
- Endoscopic ablative therapy for Barrett's esophagus: current status. (2004) (39)
- Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium. (2016) (37)
- Increased Esophageal Chemoreceptor Sensitivity to Acid in Patients After Successful Reversal of Barrett's Esophagus (1997) (37)
- Age- and gender-related differences in 24-hour esophageal pH monitoring of normal subjects (1993) (36)
- Mucosal ablation therapy of barrett esophagus. (2001) (36)
- Screening for Barrett's esophagus by balloon cytology. (1995) (34)
- Squamous mucosa overlying columnar epithelium in Barrett's esophagus in the absence of anti-reflux surgery. (1988) (33)
- Management of high-grade dysplasia in Barrett's esophagus. (1989) (31)
- Physiologic changes during colonoscopy. (1990) (31)
- Referral patterns and the results of antireflux operations in patients more than sixty years of age. (1991) (30)
- Ornithine decarboxylase assay in human colorectal mucosa. Methodologic issues of importance to quality control (1992) (28)
- Adenocarcinoma of the Esophagus and Gastric Cardia: Is There Progress in the Face of Increasing Cancer Incidence? (1999) (28)
- Management of Nondysplastic Barrett's Esophagus: Where Are We Now? (2009) (28)
- Biomarker studies in reversed Barrett's esophagus. (1999) (28)
- Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium (2002) (27)
- Progression of Barretl's esophagus to high grade dysplasia and cancer: Preliminary results of the BEST (Barrett's esophagus study) trial (2001) (27)
- Association of ablation of Barrett's esophagus with high grade dysplasia and adenocarcinoma of the gastric cardia. (2006) (26)
- A population prevalence of Barrett's esophagus--finally. (2005) (26)
- A normal initial colonoscopy after age 50 does not predict a polyp-free status for life. (1994) (26)
- Abnormal Expression of Biomarkers in Incompletely Ablated Barrett’s Esophagus (2006) (25)
- Expression of Bile Acid Transporting Proteins in Barrett's Esophagus and Esophageal Adenocarcinoma (2009) (25)
- Colorectal neoplasms and Barrett's esophagus. (1986) (25)
- Natural History of Cholelithiasis in Patients with Alcoholic Cirrhosis (Cholelithiasis in Cirrhotic Patients) (1987) (25)
- Helicobacter pylori eradication dramatically improves inflammation in the gastric cardia (2000) (23)
- Community‐acquired non‐A, non‐B hepatitis: Clinical characteristics and chronicity (1984) (22)
- Clinical outcomes in patients with a diagnosis of “indefinite for dysplasia” in Barrett’s esophagus: a multicenter cohort study (2015) (22)
- Intrafamilial cluster of hepatitis B virus infection: study of a large family in the United States. (1981) (21)
- Risk factors for Barrett's oesophagus: a life history approach to behavioural assessment in the distant past (1995) (21)
- Epidemiology, pathophysiology, and treatment of Barrett's esophagus: reducing mortality from esophageal adenocarcinoma. (2005) (20)
- Barrett's oesophagus: optimal strategies for prevention and treatment. (2003) (19)
- Randomized trials in the treatment of Barrett's esophagus. (2005) (19)
- Evaluation of hepatic injury arising during fluconazole therapy. (1994) (19)
- Barrett's esophagus: a model premalignant lesion for adenocarcinoma. (1989) (18)
- Pathological documentation of complete elimination of Barrett's metaplasia following endoscopic multipolar electrocoagulation therapy (2001) (18)
- Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium. (2019) (17)
- The rising incidence of esophageal adenocarcinoma. (2001) (17)
- GERD, DGER, or both in Barrett's esophagus? (1997) (17)
- Is the length of newly diagnosed Barrett's esophagus decreasing? The experience of a VA Health Care System. (2004) (16)
- Preventing hypoxemia during colonoscopy. A randomized controlled trial of supplemental oxygen. (1992) (16)
- Barrett's esophagus: electrocoagulation. (1999) (16)
- Critical review of the diagnosis of columnar metaplasia in the esophagus and the esophagogastric junction: the Paris workshop (2005) (15)
- Chemopreventive studies in Barrett's esophagus: a model premalignant lesion for esophageal adenocarcinoma. (1992) (15)
- Short segment Barrett's esophagus: relationship of age with extent of intestinal metaplasia (2000) (15)
- Efficacy of radiologic studies in the detection of Barrett's esophagus. (1986) (15)
- HLA antigens and HBV infection: evaluation in the chronic carrier state and in a large family. (1981) (15)
- Review article: Barrett's oesophagus--cancer risk, biology and therapeutic management. (1993) (15)
- Post-ablation biomarker abnormalities in Barrett's esophagus (BE): Are we increasing the cancer risk? (2001) (14)
- Prevention of Adenocarcinoma by Reversing Barrett’s Esophagus with Mucosal Ablation (2003) (14)
- Hepatitis B virus DNA in asymptomatic HBsAg carriers: Comparison with HBeAg/anti‐HBe status (1987) (14)
- Reduction of Acid Exposure and Regression of Barrett’s Esophagus (2001) (14)
- Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium. (2002) (14)
- The role of laser ablation and photodynamic therapy. (1995) (14)
- SHORT SEGMENT BARRETT'S ESOPHAGUS AND INTESTINAL METAPLASIA OF THE CARDIA—IT'S NOT ALL SYMANTICS!!! (1998) (13)
- The duration of hepatitis B surface antigenemia. (1979) (13)
- Reaction to hepatitis B virus vaccine. (1984) (13)
- Liver histology in anti-HCV-positive persons with normal or minimally elevated aminotransferases. (1995) (13)
- Progress report: the Arizona phase III study of the effect of wheat bran fiber on recurrence of adenomatous colon polyps. (1999) (13)
- Antireflux surgery and Barrett's esophagus regression: wheel of fortune, or to tell the truth? (1991) (13)
- Fate of high grade dysplasia at 1 year after endoscopic ablation with Nd:YAG laser and electrocautery (2000) (12)
- Chronic liver disease after acute non-A non-B viral hepatitis (1980) (12)
- The persistence and significance of elevated alanine aminotransferase levels in blood donors (1985) (12)
- Barrett's esophagus and other mucosal evidence of reflux in asymptomatic subjects with abnormal 24-hour esophageal pH monitoring (1994) (11)
- Confocal microendoscope for use in a clinical setting (2007) (11)
- Low Risk of Progression of Barrett's Esophagus to Neoplasia in Women. (2020) (10)
- 475c Low Risk of Developing Dysplasia and Esophageal Adenocarcinoma (EAC) in Patients With Non-Dysplastic Barrett's Esophagus (BE): Results From a Large, Multicenter, Cohort Study (2010) (10)
- Barrett’s esophagus, a complication of GERD (2002) (10)
- Barrett's oesophagus length is established at the time of initial endoscopy and does not change over time: results from a large multicentre cohort (2015) (10)
- Epidermal growth factor receptor overexpression and trisomy 7 in a case of Barrett's esophagus (1990) (10)
- Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer at what cost? (1994) (9)
- New treatments for Barrett's esophagus. (1997) (9)
- Detecting, measuring, and managing Barrett's esophagus: the complete endoscopist's dilemma. (1997) (9)
- Managing Barrett's esophagus: what is new in 2005? (2005) (9)
- Endoscopic therapy for Barrett's esophagus. (2009) (8)
- Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus (2002) (8)
- Chronic liver disease after acute non-A non-B viral hepatitis. (1980) (8)
- Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia (2015) (8)
- Karyometry in Barrett's esophagus. (2001) (8)
- Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus (BE) (2000) (8)
- Relationship Between Barrett's Esophagus (BE) Length and the Risk of High Grade Dysplasia (HGD) and Esophageal Adenocarcinoma (EAC) in Patients With Non Dysplastic Barrett's Esophagus Results From a Large Multicenter Cohort (2011) (8)
- Esophageal ulceration associated with 13-cis-retinoic acid therapy in patients with Barrett's esophagus. (1989) (8)
- Short-segment Barrett's esophagus. (1998) (8)
- Barrett's Esophagus and Esophageal Adenocarcinoma (2001) (7)
- Detection of Intestinal Metaplasia in Barrett's Esophagus (2007) (7)
- Flow cytometry in Barrett's esophagus: when all is said and done, more is said than done! (1993) (7)
- Long-term endoscopic surveillance of Barrett's esophagus (2003) (6)
- Impact of esophageal acid exposure on the endoscopic reversal of Barrett’s esophagus (2000) (6)
- Clinical evaluation of a confocal microendoscope system for imaging the ovary (2008) (6)
- Bile Salt Induction of Apoptosis in Goblet Cells of the Normal Human Colonic Mucosa: Relevance to Colon Cancer (1995) (6)
- Should Patients with GERD Be Screened Once at Least for Barrett's Epithelium? PRO: The Need to Screen GERD Patients for Barrett's Esophagus—A Greater Yield than Surveillance (2004) (6)
- Flow cytometry in Barrett's esophagus what have we learned so far? (1991) (6)
- Increase in ornithine decarboxylase activity associated with development of dysplasia in barrett's esophagus (1989) (6)
- Incidence of adenocarcinoma in Barrett's esophagus: Results of a multicenter prospective study. (2004) (6)
- Endoscopic antireflux procedures: a good wrap? (2005) (6)
- Chronic liver disease following community-acquired non-A, non-B hepatitis. (1986) (6)
- Frequency of Antibody to Hepatitis B in a Community Hospital Laboratory (1984) (6)
- Agreement Among Expert Gastrointestinal Pathologists for Low-Grade Dysplasia (LGD) in Barrett's Esophagus (BE) and Implications for Progression: Results From a Large, Multicenter Cohort Study (2011) (5)
- The Prevalence of Barrett's Esophagus in Veteran Patients with and Without GERD Symptoms Undergoing Outpatient Colonoscopy (2008) (5)
- 962 Decreasing Rates of Esophageal Adenocarcinoma (EAC) in Patients With Persistent Non Dysplastic Barrett's Esophagus (NDBE): Results From a Large Multicenter Cohort (2012) (5)
- M1107 Durability of Ablative Therapies in Barrett's Esophagus (BE): Long Term Results of a Randomized Controlled Trial (RCT) of Ablation With Argon Plasma Coagulation (APC) and Multipolar Electrocoagulation (MPEC) (2010) (5)
- Long-term outcome of medical and surgical therapies for GERD: Effects on GERD symptoms and signs (2000) (5)
- M1104 Predicting High-Grade Dysplasia (HGD) and Esophageal Adenocarcinoma (EAC) in Patients With Non-Dysplastic Barrett's Esophagus (BE): Results From a Large, Multicenter Cohort Study (2010) (5)
- Limitations of fecal occult blood testing. (1990) (5)
- The better burn. (2005) (5)
- Dietary fiber and colon cancer prevention (1991) (5)
- Use of blood component therapy for gastrointestinal bleeding in patients with cirrhosis of the liver. (1975) (5)
- Ablation of Barrett's mucosa. (1997) (4)
- Endoscopic polypectomy reduces mortality from colorectal cancer. (1995) (4)
- Hepatic response to parenchymal injection of sodium cholate and monooctanoin (1980) (4)
- Colon cancer reduction. Questions about implementation of proven techniques. (1997) (4)
- T1879 Low-Grade Dysplasia (LGD) Is a Poor Marker for Cancer Progression in Patients with Barrett's Esophagus (BE): Preliminary Results from a Large, Multi-Center, Cohort Study (2009) (4)
- W1876 Are Biopsies After Ablation for Dysplastic Barrett's Esophagus of Adequate Depth to Detect Glandular Mucosa Beneath the Neosquamous Epithelium? - Comparative Histopathological Outcomes from a Randomized, Sham-Controlled Trial (Aim Dysplasia Trial) (2008) (4)
- Asymptomatic parotid enlargement in Pima Indians. Relationship to age, obesity, and diabetes mellitus. (1970) (4)
- The length of newly diagnosed Barrett’s esophagus and prior use of acid suppressive therapy (2003) (4)
- The relationship between esophageal acid exposure, dysplasia and extent of columnar metaplasia in Barrett's esophagus (2000) (4)
- The yield of diagnostic upper endoscopy: results of a prospective audit. (1985) (4)
- Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach (2009) (4)
- Predominance of immunoglobulin M antibody to hepatitis B core antigen in chronic carriers of hepatitis B surface antigen. (1984) (4)
- Multipolar electrocoagulation. (2003) (4)
- Laser therapy of Barrett's mucosa. (1993) (4)
- Endoscopic evaluation of Barrett's esophagus. (1994) (4)
- Management of nondysplastic barrett esophagus with ablation therapy. (2011) (4)
- Long-term outcome of medical andsurgical therapies for gerd: Effects on survival (2000) (3)
- Demonstration of free rupture of the gallbladder by endoscopic retrograde cholangiography. (1986) (3)
- How far to go? Screening and surveillance in Barrett's esophagus. (2001) (3)
- Does Barrett's esophagus need to be detected? (1986) (3)
- Medical treatment of Barrett's esophagus: can it prevent cancer? (2009) (3)
- Chronic non-A, non-B liver disease. Need for diagnostic criteria and course definition. (1981) (3)
- Tissue culture of epithelial cells from esophageal specialized columnar epithelium (Barrett's esophagus) (1992) (3)
- Chronic active hepatitis in hepatitis B surface antigen (HBsAg) carriers. The need for liver biopsy. (1977) (3)
- Is the Extent of Low-Grade Dysplasia (LGD) in Barrett's Esophagus (BE) a Risk Factor for the Development of Esophageal Adenocarcinoma (EAC): Results From a Large, Multicenter Cohort Study (2011) (3)
- Long-term endoscopic surveillance of Barrett's esophagus. (2003) (3)
- Updated Guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus (American Journal of Gastroenterology (March 2008) 103: 3 (788)) (2008) (2)
- Barrett’s Esophagus and Adenocarcinoma (2001) (2)
- Medical therapy for gastroesophageal reflux disease. Not all treatments are equal! (1991) (2)
- Demonstration of a field defect in gastric intestinal metaplasia by biological marker analysis. (1994) (2)
- 1039 How Durable Is the Reversion to Neosquamous Epithelium in Subjects Undergoing Radiofrequency Ablation for Dysplastic Barrett's Esophagus? Two Year Follow-Up of the AIM-Dysplasia Randomized Sham-Controlled Trial (2009) (2)
- Is screening for Barrett's esophagus cost-effective? (2000) (2)
- Preoperative chemotherapy unmasks underlying Barrett’s Mucosa in patients with adenocarcinoma of the distal esophagus: Theisen J, Stein HJ, Dittler HJ, et al., Lifting the Veil on Esophageal Adenocarcinoma, Surg Endosc 2002;16:671–3 (2003) (2)
- S1056 The Prevalence of Dysplasia is Increasing in Patients With Newly Diagnosed Barrett's Esophagus (BE): Secular Trends From a Large, Multicenter, Cohort Study (2010) (2)
- M1995 InterSPORE/EDRN Barrett's Esophagus (BE) Study: Interim Report of a Multicenter Case-Control Study of Progressors to High-Grade Dysplasia/Adenocarcinoma vs. Nonprogressors (2008) (2)
- Are H2 blockers for symptom relief? (1986) (2)
- Erratum: Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas (New England Journal of Medicine (April 20, 2000) 342 (1156-1162)) (2000) (2)
- False-positive secretin-KABI provocation test associated with achlorhydria. (1988) (2)
- Polymeric endoesophageal paving: A biodegradable alternative to stenting (1998) (2)
- Preoperative Chemotherapy Unmasks Underlying Barrett's Mucosa in Patients With Adenocarcinoma of the Distal Esophagus (2003) (2)
- Interobserver Agreement for the Detection of Barrett's Esophagus (BE) with Esophageal Capsule Endoscopy (ECE) (2007) (2)
- Proton pump inhibitors reduce the incidence of dysplasia in Barrett’s esophagus (2003) (2)
- Management of premalignant esophagogastric lesions. (1982) (2)
- Subsquamous Intestinal Metaplasia Is a Common Finding in Ablation-Naïve Patients with Dysplastic Barrett's Esophagus, and Significantly Decreases in Prevalence After Radiofrequency Ablation (2008) (2)
- Yield of Routine Endoscopy Beyond the Duodenal Bulb (1997) (2)
- Hereditary hemorrhagic telangiectasia in three black men. (1978) (2)
- Correlation between the height of abnormal acid reflux and the length of Barrett's esophagus (2000) (2)
- Limitations of combined flexible sigmoidoscopy and double contrast barium enema in patients with rectal bleeding. (1989) (2)
- M1957 Expression of Bile Acid Transporting Proteins in Barrett's Esophagus and Esophageal Adenocarcinoma (2008) (1)
- 1035 The Use of FISH in a Multi-Center Blinded Study to Predict Development of Neoplasia in Barrett's Esophagus (2009) (1)
- Reversal of Barrett's esophagus with high dose omeprazole and electrocoagulation 6 month follow-up (2000) (1)
- Appearance and prognosis of dysplasia in Barrett's esophagus. (2002) (1)
- Reversal of Barrett’s esophagus with electrocoagulation and laser (2000) (1)
- The Association of Barrettʼs Esophagus and Body Mass Index: 5 (2005) (1)
- CLINICAL—ALIMENTARY TRACT Risk Factors for Progression of Low-Grade Dysplasia in Patients With Barrett's Esophagus (2011) (1)
- Barrett’s Esophagus: A Special Diagnostic Problem (1994) (1)
- Barrett esophagus. (2000) (1)
- Risk for cancer in Barrett’s esophagus: Medical versus surgical therapy (2007) (1)
- IL-6 expression and secretion is increased in patients with Barrett's esophagus (2003) (1)
- The clinical significance of the hepatitis B surface antigen. (1979) (1)
- Endoscopic therapy for barrett's high-grade dysplasia: entering the therapeutic arena. (2007) (1)
- Isolated Antibody to Hepatitis B Core Antigen and the Immune Response to Hepatitis B Vaccination,-Reply (1988) (1)
- Development and Validation of a Prediction Model Associated with Neoplastic Progression of Barrettʼs Esophagus (BE): Data from a Multi-Center Prospective Cohort: 426 (2016) (1)
- High Prevalence of Metabolic Syndrome in Patients with Barrett's Esophagus: A Multi-Center, Registry Study (2009) (1)
- Please, not another marker of cancer risk in Barrett's esophagus! (1995) (1)
- Hepatitis B in the dental setting: dental hygienists. (1978) (1)
- Cytokeratin 7 & 20 staining patterns in patients with cardia intestinal metaplasia associated with either Barrett's esophagus or H. pylori (2000) (1)
- M1021 Thermal Ablation of Barrett's Esophagus: A 6 year Follow-Up (2008) (1)
- 710 Proton Pump Inhibitor Use but Not Statin Use Is Associated With Decreased Risk for High-grade Dysplasia and Esophageal Adenocarcinoma in Patients With Barrett's Esophagus: Results From a Large, Multicenter Cohort Study (2014) (1)
- The liver disease of asymptomatic patients with Elevated Aminotransferases (1989) (1)
- The length of newly diagnosed Barrett's esophagus and prior use of acid suppressive therapy (2003) (1)
- Response to Drs. Romero and Riddell (1998) (0)
- 197 A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus (2009) (0)
- W1051 Adherence to Surveillance Interval Guidelines in Barrett's Esophagus (BE): Analysis From a Large Multicenter Cohort Study (2010) (0)
- Incidence of adenocarcinoma in Barrett's esophagus: Results of a multicenter prospective study (2004) (0)
- The Dilemma of the HBsAg-Positive Physician (1978) (0)
- The recognition of early liver disease. (1989) (0)
- Hepatitis B vaccine (1983) (0)
- Update on Screening, Surveillance, and Treatment (2015) (0)
- Renal and gastric hamartomas. (1979) (0)
- Proton pump inhibitor (PPI) treatment may not alter malignant progression in cases of Barrett's metaplasia (BM) showing p53 protein accumulation (2000) (0)
- Short segment Barrett's esophagus (SSBE): relation of age with extent of intestinal metaplasia (2000) (0)
- 6947 Squamous overgrowth of barrett's metaplasia after multipolar electrocoagulation (mpec) is not a widespread phenomenon: an endoscopic ultrasound study. (2000) (0)
- Contents Vol. 18 (2001) (0)
- Surveillance of Barrett's esophagus (2010) (0)
- Proton pump inhibitor (PPI) treatment may not alter malignant progression in cases of Barrett’s metaplasia (BM) showing p53 protein accumulation (2000) (0)
- Book Reviews (1947) (0)
- Sa1255 Low Risk of Neoplastic Progression of Barrett's Esophagus in Women: Results From a Large Multi-Center Consortium (2016) (0)
- Book reviews (2005) (0)
- Faculty Opinions recommendation of Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. (2006) (0)
- Chapter 7 – Barrett's Esophagus (2010) (0)
- Print and Media Review (2010) (0)
- Faculty Opinions recommendation of NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. (2007) (0)
- Clinical trials of differentiation therapy of solid tumors176. Upper GI tract premalignant lesions: Barrett's esophagus and gastric intestinal metaplasia (1992) (0)
- Esophageal cancer and barrett's esophagus: Sharma/Esophageal cancer and barrett's esophagus (2015) (0)
- Book reviews (2005) (0)
- Tu1132 - Barrett's Esophagus Patients with Non-Dysplastic Visible Mucosal Lesions have a Higher Risk of Neoplastic Progression: Results from a Large Multi-Center Consortium (2018) (0)
- Esophageal cancer and barrett’s esophagus Esophageal cancer and barrett’s esophagus (2015) (0)
- Evaluation of the patient with jaundice--1984. (1984) (0)
- Plasmapheresis of hepatitis B surface antigen carriers. (1980) (0)
- Finding the needle in the haystack: identifying the high-risk "premalignant" gastric lesion. (2008) (0)
- The dilemma of the HBsAg-positive physician. An approach to preventing transmission. (1978) (0)
- Effect of multipolar electrocoagulation on the endosonography of Barrett’s esophagus (2000) (0)
- Screening for Barrett's Esophagus: Targeting High Risk Patients (2007) (0)
- Chemoreceptor sensitivity and esophageal motor function before and after reversal of Barrett's espohagus (BE) with endoscopic multipolar electrocoagulation (MPEC) (2001) (0)
- Tu1102 Are Clinical Outcomes in Indefinite for Dysplasia (IND) Any Different From Low Grade Dysplasia (LGD) in Patients With Barrett's Esophagus (BE)? Results From a Large Multicenter Cohort Study (2012) (0)
- Neoplastic Progression in Patients with Short Segment Barrett's Esophagus: Long-Term Follow-up of Over a 1000 Patients in a Multi-Center Consortium (2017) (0)
- Frequency of heartburn and severity of dysphagia are the only symptom characteristics that distinguish long segment Barrett’s from short segment Barrett’s esophagus (2004) (0)
- Response to Dr. Kelty et al. (2008) (0)
- Duration of Heartburn Is the Only Symptom Characteristic That Distinguishes Between Patients with Long Segment (LSBE) and Those with Short Segment Barrett's Esophagus (SSBE) (2004) (0)
- A surgical experience suggesting the threshold for endoscopic therapy. (2009) (0)
- Mo1894 Barrett's Esophagus Length Is Determined At the Time of Initial Development and Does Not Change Over Time: Results From a Large Multicenter Cohort (2013) (0)
- Evaluation of the patient with jaundice--1984. (1984) (0)
- LASER THERAPY OF BARRETT'S MUCOSA. RESPONSE (1993) (0)
- Comprar Endoscopic Therapy for Barrett's Esophagus | Sampliner, Richard E. | 9781603274449 | Springer (2009) (0)
- Clinical and Endoscopic Characteristics of a Large Cohort of Barrett's Esophagus (BE) Patients with Low and High-Grade Dysplasia (2008) (0)
- Scintigraphic assessment of Barrett's esophagus (1984) (0)
- Increased Recognition of HGD/EAC at Index Endoscopy Over the Past 2 Decades: Data from a Multi-Center U.S. Consortium (2017) (0)
- Subject Index Vol. 18 (2001) (0)
- MEDICAL THERAPY FOR BARRETT'S ESOPHAGUS (2008) (0)
- A Randomized Controlled Trial of Ablation of Barrett's Esophagus With Electrocautery Vs. Argon Plasma Coagulation: Long Term Results (2005) (0)
- Asymptomatic Parotid Enlargement in Pima Indians (2020) (0)
- Faculty Opinions recommendation of Appropriateness of upper-GI endoscopy: an Italian survey on behalf of the Italian Society of Digestive Endoscopy. (2007) (0)
- Color Plate Section (2006) (0)
- 9 - Barrett's Esophagus International Consortium Study: Detection of Post-Endoscopy Neoplastic Progression in Patients Undergoing Surveillance (2018) (0)
- CLINICAL-ALIMENTARY TRACT Five-Year Colon Surveillance After Screening Colonoscopy (2007) (0)
- M1099 Do Numeracy Skills Impact Cancer Risk Perception in Barrett's Esophagus? (2010) (0)
- Proton Pump Inhibitor and Nonsteroidal Anti-Inflammatory Use and the Development of Neoplasia in Barrettʼs Esophagus: 11 (2007) (0)
- The methylene blue blues. (2006) (0)
- Is Their a Preferred Location of Intestinal Metaplasia in Barrett's Esophagus? (2007) (0)
- Barrett's oesophagus and development of dysplasia and adenocarcinoma. (1993) (0)
- Low plasma selenium concentration is associated with elevated risk to neoplastic polyps of the colon (1991) (0)
- edication Usage and the Risk of Neoplasia in Patients ith Barrett ’ s Esophagus (0)
- Short segment Barrett's esophagus (SSBE): variation in length with endoscopic follow up (2000) (0)
- Comprar Gastrointestinal Oncology: A Critical Multidisciplinary Approach | Yuman Fong | 9781405127837 | Blackwell Publishing (2008) (0)
- Diagnosing and managing Barrett's esophagus. (2000) (0)
- Long term follow up of dysplasia in patients with short segment barretts esophagus (SSBE) (1997) (0)
- The prevalence of barretts esophagus in hispanic patients undergoing endoscopy is similar to causasian patients (1997) (0)
- Assessment of symptom severity and chemosensitivity to acid in elderly versus young patients with gastroesophageal reflux disease (GERD) (1998) (0)
- AbstractShort segment Barrett’s esophagus (SSBE): relation of age with extent of intestinal metaplasia (2000) (0)
- Guidelines for the serodiagnosis of acute viral hepatitis. (1981) (0)
- Proton pump inhibitors reduce the incidence of dysplasia in Barrett's esophagus (2003) (0)
- Dose escalation of proton pump inhibitor (PPI) therapy during endoscopic ablation of Barrett's esophagus (BE) (2003) (0)
- At Last—A Treatment for IBS Beyond Placebo (2003) (0)
- Variceal heavyweights: the ring versus the needle. (1993) (0)
- Long-term effect of alpha-interferon therapy in chronic hepatitis B. (1991) (0)
- Sa1850 Should We Continue to Follow Patients With <1 CM Barrett's Esophagus (Irregular Z Line): Results From a Large, Multicenter, Cohort Study (2014) (0)
- Effect of acid suppression on the development of dysplasia/cancer in patients with barrett's esophagus (2000) (0)
- WORLD LITERATURE REVIEWS (2003) (0)
- Endoscopic thermal reversal of barrett's esophagus (2000) (0)
- Gastrointestinal emergencies: Edited by Mark B. Taylor, John L. Gollan, Mark Peppercorn, Michael Steer, and M. Michael Wolfe. 615 pp. $105.00. Williams & Wilkins, Baltimore, Maryland, 1992. ISBN 0-683-08107-1 (1993) (0)
- High-grade dysplasia in Barrett's esophagus: an evolving clinical dilemma. (1993) (0)
- Mo1006 - A Detailed Analysis of the Characteristics and Histology of Visible Mucosal Abnormalities in Patients Undergoing Surveillance Endoscopy for Barrett's Esophagus (BE): Results from a Multicenter Cohort (2018) (0)
- 839 Should We Discontinue Surveillance in Patients With Irregular z line (<1 cm Barrett's Esophagus): Results from a Large, Multicenter, Cohort Study (2016) (0)
- INFLUENCE OF ASCITES ON TOBRAMICIN PHARMACOKINTIC (1984) (0)
- Immune globulin prophylaxis for viral hepatitis: to give or not to give. (1980) (0)
- Effect of multipolar electrocoagulation on the endosonography of Barrett's esophagus (2000) (0)
- Faculty Opinions recommendation of Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. (2008) (0)
- Musculoskeletal Injuries Among Gastroenterologists; Is Colonoscopy The Culprit?: 1350 (2009) (0)
- Tu1079 Adherence to Surveillance Guidelines in Patients With Barrett's Esophagus (BE): Analysis From a Large Multicenter Cohort Study (2014) (0)
- Anti-HBc and tissue B viral antigens. (1979) (0)
- Barrett esophagus. (2002) (0)
- Developments in Barrett's esophagus. (2006) (0)
- Faculty Opinions recommendation of Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked. (2007) (0)
- Defining the Rates of Missed and Interval High-Grade Lesions in Patients With Barrettʼs Esophagus: Results From a Large Multicenter Study: 308 (2017) (0)
- Faculty Opinions recommendation of Low-grade dysplasia in Barrett's esophagus has a high risk of progression. (2007) (0)
- Chronic Active Hepatitis: The Mayo Clinic Experience (1987) (0)
- Yield of routine endoscopy beyond the duodenal bulb. (1995) (0)
- The Berkson principle versus the Mainland-Cornfield principle. (1973) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Richard E. Sampliner?
Richard E. Sampliner is affiliated with the following schools:
